-
1
-
-
33746588738
-
The epidemiology of multiple sclerosis in Europe
-
Pugliatti M, Rosati G, Carton H et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006;13:700-22.
-
(2006)
Eur J Neurol
, vol.13
, pp. 700-722
-
-
Pugliatti, M.1
Rosati, G.2
Carton, H.3
-
2
-
-
84888352123
-
Natural history of multiple sclerosis symptoms
-
Kister I, Bacon TE, Chamot E et al. Natural history of multiple sclerosis symptoms. Int J MS Care 2013;15:146-58.
-
(2013)
Int J MS Care
, vol.15
, pp. 146-158
-
-
Kister, I.1
Bacon, T.E.2
Chamot, E.3
-
4
-
-
84867255279
-
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids
-
Oreja-Guevara C. Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids. Rev Neurol 2012;55:421-30.
-
(2012)
Rev Neurol
, vol.55
, pp. 421-430
-
-
Oreja-Guevara, C.1
-
5
-
-
84893105135
-
Spasticity in patients with multiple sclerosis-clinical characteristics, treatment and quality of life
-
Flachenecker P, Henze T, Zettl UK. Spasticity in patients with multiple sclerosis-clinical characteristics, treatment and quality of life. Acta Neurol Scand 2014;129:154-62.
-
(2014)
Acta Neurol Scand
, vol.129
, pp. 154-162
-
-
Flachenecker, P.1
Henze, T.2
Zettl, U.K.3
-
7
-
-
33847766180
-
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
-
Collin C, Davies P, Mutiboko IK, Ratcliff S. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol 2007;14:290-6.
-
(2007)
Eur J Neurol
, vol.14
, pp. 290-296
-
-
Collin, C.1
Davies, P.2
Mutiboko, I.K.3
Ratcliff, S.4
-
8
-
-
77952835462
-
®, in subjects with symptoms of spasticity due to multiple sclerosis
-
®, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res 2010;32:451-9.
-
(2010)
Neurol Res
, vol.32
, pp. 451-459
-
-
Collin, C.1
Ehler, E.2
Waberzinek, G.3
-
9
-
-
79953822342
-
®®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
-
®®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 2011;18:1122-31.
-
(2011)
Eur J Neurol
, vol.18
, pp. 1122-1131
-
-
Novotna, A.1
Mares, J.2
Ratcliffe, S.3
-
10
-
-
33745025055
-
Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
-
Wade DT, Makela PM, House H, Batman C, Robson P. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler 2006;12:639-45.
-
(2006)
Mult Scler
, vol.12
, pp. 639-645
-
-
Wade, D.T.1
Makela, P.M.2
House, H.3
Batman, C.4
Robson, P.5
-
13
-
-
84872287267
-
® long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
-
® long-term use: an open-label trial in patients with spasticity due to multiple sclerosis. J Neurol 2013;260:285-95.
-
(2013)
J Neurol
, vol.260
, pp. 285-295
-
-
Serpell, M.G.1
Notcutt, W.2
Collin, C.3
-
14
-
-
84884180640
-
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)
-
Fernandez O, Arnal-Garcia C, Arroyo-Gonzalez R et al. Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II). Rev Neurol 2013;57:269-81.
-
(2013)
Rev Neurol
, vol.57
, pp. 269-281
-
-
Fernandez, O.1
Arnal-Garcia, C.2
Arroyo-Gonzalez, R.3
-
15
-
-
46049119745
-
Adverse effects of medical cannabinoids: a systematic review
-
Wang T, Collet J, Shapiro S, Ware MA. Adverse effects of medical cannabinoids: a systematic review. CMAJ 2008;178:1669-78.
-
(2008)
CMAJ
, vol.178
, pp. 1669-1678
-
-
Wang, T.1
Collet, J.2
Shapiro, S.3
Ware, M.A.4
-
16
-
-
84868245558
-
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
-
Leussink VI, Husseini L, Warnke C, Broussalis E, Hartung HP, Kieseier BC. Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. Ther Adv Neurol Disord 2012;5:255-66.
-
(2012)
Ther Adv Neurol Disord
, vol.5
, pp. 255-266
-
-
Leussink, V.I.1
Husseini, L.2
Warnke, C.3
Broussalis, E.4
Hartung, H.P.5
Kieseier, B.C.6
-
19
-
-
84873393356
-
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain
-
Garcia-Merino A. Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain. Expert Rev Neurother 2013;13(3 Suppl 1):9-13.
-
(2013)
Expert Rev Neurother
, vol.13
, Issue.3
, pp. 9-13
-
-
Garcia-Merino, A.1
-
20
-
-
0021035886
-
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)
-
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
-
(1983)
Neurology
, vol.33
, pp. 1444-1452
-
-
Kurtzke, J.F.1
-
21
-
-
44849131341
-
Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial
-
Farrar JT, Troxel AB, Stott C, Dunconmbe B, Jensen MP. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin Ther 2008;30:974-85. http://www.sciencedirect.com/science/article/pii/S0149291808001811.
-
(2008)
Clin Ther
, vol.30
, pp. 974-985
-
-
Farrar, J.T.1
Troxel, A.B.2
Stott, C.3
Dunconmbe, B.4
Jensen, M.P.5
-
22
-
-
0026333617
-
A new method for measuring daytime sleepiness: the Epworth sleepiness scale
-
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
-
(1991)
Sleep
, vol.14
, pp. 540-545
-
-
Johns, M.W.1
-
25
-
-
84977787651
-
A survey of advice on driving in neurological conditions amongst neurologists and neurosurgeons
-
Wong SL, Sharrack B. A survey of advice on driving in neurological conditions amongst neurologists and neurosurgeons. J Neurol Neurosurg Psychiatry 2013;84:e2.
-
(2013)
J Neurol Neurosurg Psychiatry
, vol.84
, pp. e2
-
-
Wong, S.L.1
Sharrack, B.2
-
26
-
-
84879924024
-
Driving performance in persons with mild to moderate symptoms of multiple sclerosis
-
Devos H, Brijs T, Alders G, Wets G, Feys P. Driving performance in persons with mild to moderate symptoms of multiple sclerosis. Disabil Rehabil 2013;35:1387-93.
-
(2013)
Disabil Rehabil
, vol.35
, pp. 1387-1393
-
-
Devos, H.1
Brijs, T.2
Alders, G.3
Wets, G.4
Feys, P.5
-
27
-
-
49949092721
-
The contribution of cognition and spasticity to driving performance in multiple sclerosis
-
Marcotte TD, Rosenthal TJ, Roberts E et al. The contribution of cognition and spasticity to driving performance in multiple sclerosis. Arch Phys Med Rehabil 2008;89:1753-8.
-
(2008)
Arch Phys Med Rehabil
, vol.89
, pp. 1753-1758
-
-
Marcotte, T.D.1
Rosenthal, T.J.2
Roberts, E.3
-
28
-
-
84874353280
-
Predictors of driving in individuals with relapsing-remitting multiple sclerosis
-
Akinwuntan AE, Devos H, Stepleman L et al. Predictors of driving in individuals with relapsing-remitting multiple sclerosis. Mult Scler 2013;19:344-50.
-
(2013)
Mult Scler
, vol.19
, pp. 344-350
-
-
Akinwuntan, A.E.1
Devos, H.2
Stepleman, L.3
-
29
-
-
42149124914
-
Cognitive abilities as predictors of safety to drive in people with multiple sclerosis
-
Lincoln NB, Radford KA. Cognitive abilities as predictors of safety to drive in people with multiple sclerosis. Mult Scler 2008;14:123-8.
-
(2008)
Mult Scler
, vol.14
, pp. 123-128
-
-
Lincoln, N.B.1
Radford, K.A.2
-
30
-
-
77949293828
-
Examining the relationship between cognition and driving performance in multiple sclerosis
-
Schultheis MT, Weisser V, Ang J et al. Examining the relationship between cognition and driving performance in multiple sclerosis. Arch Phys Med Rehabil 2010;91:465-73.
-
(2010)
Arch Phys Med Rehabil
, vol.91
, pp. 465-473
-
-
Schultheis, M.T.1
Weisser, V.2
Ang, J.3
|